Skip to main content

Dr. Mackall is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Mackall's full profile

Already have an account?

  • Office

    725 Welch Rd
    Palo Alto, CA 94304
    Phone+1 650-497-8000
    Fax+1 650-497-8959

Education & Training

  • National Capital Consortium
    National Capital ConsortiumFellowship, Pediatric Hematology/Oncology, 1989 - 1992
  • Akron General Medical Center/NEOMED
    Akron General Medical Center/NEOMEDResidency, Internal Medicine, 1984 - 1988
  • Northeast Ohio Medical University
    Northeast Ohio Medical UniversityClass of 1984

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2016 - 2025
  • OH State Medical License
    OH State Medical License 1984 - 2018
  • MD State Medical License
    MD State Medical License 1994 - 2017
  • DC State Medical License
    DC State Medical License 1994 - 1998
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Whos Who in Medicine and Healthcare Marquis Whos Who
  • Elected Member The American Society for Clinical Investigation, 2005

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Fludarabine and Neurotoxicity in Engineered T-cell Therapy  
    Elliot Norry, Crystal L Mackall, Nature
  • Tumor Antigen Escape from CAR T-cell Therapy  
    Crystal L Mackall, Robbie G Majzner, Clinical Cancer Research

Abstracts/Posters

  • Identification of Dual Positive CD19+/CD3+ T Cells in an Apheresis Product Undergoing Chimeric Antigen Receptor (CAR) Transduction
    Crystal L. Mackall, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Detectable Circulating Tumor DNA 28 Days after the CD19 CAR T-Cell Therapy, Axicabtagene Ciloleucel, Is Associated with Poor Outcomes in Patients with Diffuse Large B-...
    Crystal L. Mackall, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Allogeneic Chimeric Antigen Receptor-Invariant Natural Killer T Cells Exert Both Direct and Indirect Antitumor Effects through Host CD8 T Cell Cross-Priming
    Crystal L. Mackall, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Plenary 
    American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/3/2019

Press Mentions

  • Access4Kids: A New Model to Pay for Pediatric Cell and Gene Therapies
    Access4Kids: A New Model to Pay for Pediatric Cell and Gene TherapiesAugust 22nd, 2024
  • Closing the ‘Valley of Death’: Pioneering – and Paying for – New Therapies
    Closing the ‘Valley of Death’: Pioneering – and Paying for – New TherapiesJuly 19th, 2024
  • The Race to Supercharge Cancer-Fighting T Cells
    The Race to Supercharge Cancer-Fighting T CellsJanuary 25th, 2023
  • Join now to see all

Grant Support

  • Immunobiology And Immunotherapy Of Pediatric TumorsNational Cancer Institute2011
  • Biology And Therapy Of LymphopeniaNational Cancer Institute2011
  • Clinical Program In Pediatric SarcomasNational Cancer Institute2010–2011
  • Immunobiology Of Pediatric TumorsNational Cancer Institute2010
  • Developing Immune Based TherapiesNational Cancer Institute2010
  • Biology Of T Cell DepletionNational Cancer Institute2010
  • Immunobiology Of Pediatric TumorsDivision Of Basic Sciences - Nci2009
  • Developing Immune Based TherapiesDivision Of Basic Sciences - Nci2009
  • Clinical Program In Pediatric SarcomasDivision Of Basic Sciences - Nci2009
  • Biology Of T Cell DepletionDivision Of Basic Sciences - Nci2009
  • Developing Immune Based TherapiesNational Cancer Institute2008
  • Clinical Program In Pediatric SarcomasNational Cancer Institute2008
  • Biology Of T Cell DepletionNational Cancer Institute2008
  • Immunobiology And Immunotherapy Of Pediatric TumorsNational Cancer Institute2007
  • Biology And Therapy Of T Cell DepletionNational Cancer Institute2007
  • Immunobiology And Immunotherapy Of Pediatric TumorsDivision Of Clinical Sciences - Nci2003–2006
  • Biology And Therapy Of T Cell DepletionDivision Of Clinical Sciences - Nci2003–2006
  • Clinical Trials Of Immune Reconstitution/Tumor VaccinatiDivision Of Clinical Sciences - Nci2001–2002
  • Directing T Cell Responses During Immune ReconstitutionDivision Of Clinical Sciences - Nci1999–2002
  • Clinical Trials Of Immune Reconstitution/Tumor Vaccination In Pediatric SarcomasDivision Of Clinical Sciences - Nci1999–2000
  • Directing Immune Responses During Immune ReconstitutionDivision Of Clinical Sciences - Nci1998